David Abramowitz will discuss the "Essentials of Hatch-Waxman and BPCIA on Key Agencies Overview: Understanding the Jurisdiction and Interplay of the FDA and PTO in the Patenting of Drugs and Biologics" as part of ACI’s Hatch-Waxman and BPCIA Proficiency Series on October 10, 2023.
ACI’s Hatch-Waxman and BPCIA Proficiency Series is a three week virtual series designed to provide new lawyers and executives to the life sciences industry with a foundation for understanding the essentials and intricacies of Hatch-Waxman and BPCIA litigation and regulation.
Learn more about ACI’s Hatch-Waxman and BPCIA Proficiency Series.
Sign up for our newsletter and get the latest to your inbox.